Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes
Here, we propose the extension of the quality-by-design (QbD) concept to also fit the early development phases of pharmaceuticals by adding elements that are currently widely applied, but not yet included in the QbD model in a structured way. These are the introduction of a ‘zero’ preformulation...
Elmentve itt :
| Szerzők: | |
|---|---|
| Dokumentumtípus: | Cikk |
| Megjelent: |
2018
|
| Sorozat: | DRUG DISCOVERY TODAY
23 No. 7 |
| doi: | 10.1016/j.drudis.2018.03.012 |
| mtmt: | 3356511 |
| Online Access: | http://publicatio.bibl.u-szeged.hu/14514 |
| LEADER | 01839nab a2200229 i 4500 | ||
|---|---|---|---|
| 001 | publ14514 | ||
| 005 | 20190125160726.0 | ||
| 008 | 190125s2018 hu o 0|| angol d | ||
| 022 | |a 1359-6446 | ||
| 024 | 7 | |a 10.1016/j.drudis.2018.03.012 |2 doi | |
| 024 | 7 | |a 3356511 |2 mtmt | |
| 040 | |a SZTE Publicatio Repozitórium |b hun | ||
| 041 | |a angol | ||
| 100 | 2 | |a Pannonhalminé Csóka Ildikó | |
| 245 | 1 | 0 | |a Extension of quality-by-design concept to the early development phase of pharmaceutical R&D processes |h [elektronikus dokumentum] / |c Pannonhalminé Csóka Ildikó |
| 260 | |c 2018 | ||
| 300 | |a 1340-1343 | ||
| 490 | 0 | |a DRUG DISCOVERY TODAY |v 23 No. 7 | |
| 520 | 3 | |a Here, we propose the extension of the quality-by-design (QbD) concept to also fit the early development phases of pharmaceuticals by adding elements that are currently widely applied, but not yet included in the QbD model in a structured way. These are the introduction of a ‘zero’ preformulation phase (i.e., selection of drug substance, possible dosage forms and administration routes based on the evaluated therapeutic need); building in stakeholders’ (industry, patient, and regulatory) requirements into the quality target product profile (QTTP); and the use of modern quality management tools during the composition and process design phase [collecting critical quality attributes (CQAs) and selection of CPPs) for (still laboratory-scale) design space (DS) development. Moreover, during industrial scale-up, CQAs (as well as critical process parameters; CPPs) can be changed; however, we recommend that the existing QbD elements are reconsidered and updated after this phase. | |
| 700 | 0 | 1 | |a Pallagi Edina |e aut |
| 700 | 0 | 1 | |a Paál Tamás |e aut |
| 856 | 4 | 0 | |u http://publicatio.bibl.u-szeged.hu/14514/1/10_1-s2.0-S1359644617305688-main2.pdf |z Dokumentum-elérés |